Ligand profile
CHEMBL1320799
Bioactivity hit from ChEMBL on a similar protein.
Bound to: KP13_02160 — Phosphoglycerate kinase
Identifiers
Database identifiers and provenance.
- Ligand ID
CHEMBL1320799- UniProt (similar protein)
Q4GZG4- Target protein
- KP13_02160
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 138.2
- −1 ≤ LogP ≤ 5 1.56
- MW ≤ 500 Da 294.3
- LogP ≤ 5 1.56
- H-bond donors ≤ 5 3
- H-bond acceptors ≤ 10 7
- Rotatable bonds ≤ 10 3
- TPSA ≤ 140 Ų 138.2
Matches PAINS filter: azo_A(324). May be a frequent false positive in HTS — review carefully.
Chemical representations
Canonical representations for cheminformatics workflows.
NS(=O)(=O)c1ccc(N=Nc2ccc(O)nc2O)cc1NS(=O)(=O)c1ccc(N=Nc2ccc(O)nc2O)cc1
InChI=1S/C11H10N4O4S/c12-20(18,19)8-3-1-7(2-4-8)14-15-9-5-6-10(16)13-11(9)17/h1-6H,(H2,12,18,19)(H2,13,16,17)InChI=1S/C11H10N4O4S/c12-20(18,19)8-3-1-7(2-4-8)14-15-9-5-6-10(16)13-11(9)17/h1-6H,(H2,12,18,19)(H2,13,16,17)
NVVKOBSVOCFOEN-UHFFFAOYSA-NNVVKOBSVOCFOEN-UHFFFAOYSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- ChEMBL
- Activity
- active
- Binding sites
- PF00162
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ChEMBL ChEMBL compound CHEMBL1320799 →
- UniProt UniProt Q4GZG4 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “CHEMBL1320799”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_02160.
ChEMBL 99
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).